Evidence map›Paper›PMID 40889082›Full record

Observational studyCNS drugs2025

International Trends in Opioid Prescribing by Age and Sex from 2001 to 2019: An Observational Study Using Population-Based Databases from 18 Countries and One Special Administrative Region.

Adrienne Y L Chan, Shahram Bahmanyar, Kebede Beyene, Greta Bushnell, Bruce Carleton, Amy Hai Yan Chan, Sharon Cook, Stephen Crystal, Kari Furu, Svetla Gadzhanova and 38 more

Abstract readObservational Study
In one paragraph

Observational study in CNS drugs, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

48 authors.

Adrienne Y L ChanDepartment of Pharmacology and Pharmacy, Li Ka Shing Faculty of Medicine, University of Hong Kong, Hong Kong, China.
Shahram BahmanyarDepartment of Medicine Solna, Centre for Pharmacoepidemiology, Karolinska Institutet, Stockholm, Sweden.
Kebede BeyeneSchool of Pharmacy, Faculty of Medical and Health Sciences, The University of Auckland, Auckland, New Zealand.
Greta BushnellRutgers School of Public Health, Piscataway, and the Rutgers Center for Pharmacoepidemiology and Treatment Science, Rutgers University, New Brunswick, NJ, USA.
Bruce CarletonDivision of Translational Therapeutics, Department of Pediatrics, Faculty of Medicine, University of British Columbia, Vancouver, Canada.
Amy Hai Yan ChanSchool of Pharmacy, Faculty of Medical and Health Sciences, The University of Auckland, Auckland, New Zealand.
Sharon CookCenter for Health Services Research, Institute for Health, Health Care Policy and Aging Research, Rutgers University, New Brunswick, NJ, USA.
Stephen CrystalCenter for Health Services Research, Institute for Health, Health Care Policy and Aging Research, Rutgers University, New Brunswick, NJ, USA.
Kari FuruDepartment of Chronic Diseases, Norwegian Institute of Public Health, Oslo, Norway.
Svetla GadzhanovaClinical and Health Sciences, Quality Use of Medicines and Pharmacy Research Centre, University of South Australia, Adelaide, SA, Australia.
Patricia García PozaDivision of Pharmacoepidemiology and Pharmacovigilance, Spanish Agency of Medicines and Medical Devices (AEMPS), Madrid, Spain.
Rosa GiniAgenzia regionale di sanità della Toscana, Osservatorio di epidemiologia, Florence, Italy.
Sabrina GiomettoUnit of Biostatistics, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
Jeff HarrisonSchool of Pharmacy, Faculty of Medical and Health Sciences, The University of Auckland, Auckland, New Zealand.
Ulrike HaugDepartment of Clinical Epidemiology, Leibniz Institute for Prevention Research and Epidemiology-BIPS, Bremen, Germany.
Christine HsuDepartment of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
Harpa Lind Hjördísar JónsdóttirFaculty of Psychology, University of Iceland, Reykjavík, Iceland.
Joe KaiPrimary Care Stratified Medicine (PRISM) research group, School of Medicine, University of Nottingham, Nottingham, UK.
Øystein KarlstadDepartment of Chronic Diseases, Norwegian Institute of Public Health, Oslo, Norway.
Ju Hwan KimSchool of Pharmacy, Sungkyunkwan University, Suwon, Gyeonggi-do, South Korea.
Kiyoshi KubotaNPO Drug Safety Research Unit Japan, Tokyo, Japan.
Edward Chia-Cheng LaiSchool of Pharmacy, Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Tainan, Taiwan.
Hyesung LeeDepartment of Medical Informatics, Kangwon National University College of Medicine, Chuncheon, Korea.
Wallis C Y LauDepartment of Pharmacology and Pharmacy, Li Ka Shing Faculty of Medicine, University of Hong Kong, Hong Kong, China.
Kathy H LiDivision of Translational Therapeutics, Department of Pediatrics, Faculty of Medicine, University of British Columbia, Vancouver, Canada.
Ersilia LucenteforteDepartment of Statistics, Computer Sciences and Applications G. Parenti, University of Florence, Florence, Italy.
Géric MauraFrench National Health Insurance (Caisse Nationale de L'Assurance Maladie, Cnam), 50 Avenue du Pr. André Lemierre, 75 986, Paris Cedex 20, France.
Anke NeumannFrench National Health Insurance (Caisse Nationale de L'Assurance Maladie, Cnam), 50 Avenue du Pr. André Lemierre, 75 986, Paris Cedex 20, France.
Virginia PateDepartment of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
Anton PottegårdClinical Pharmacology, Pharmacy and Environmental medicine, Department of Public Health, University of Southern Denmark, Odense, Denmark.
Nadeem QureshiPrimary Care Stratified Medicine (PRISM) research group, School of Medicine, University of Nottingham, Nottingham, UK.
Lotte RasmussenClinical Pharmacology, Pharmacy and Environmental medicine, Department of Public Health, University of Southern Denmark, Odense, Denmark.
Johan ReutforsDepartment of Medicine Solna, Centre for Pharmacoepidemiology, Karolinska Institutet, Stockholm, Sweden.
Elizabeth E RougheadClinical and Health Sciences, Quality Use of Medicines and Pharmacy Research Centre, University of South Australia, Adelaide, SA, Australia.
Leena SaastamoinenResearch Unit, The Social Insurance Institution of Finland, Kela, PO Box 450, 00056, Helsinki, Finland.
Tsugumichi SatoDepartment of Pharmacy, Faculty of Pharmaceutical Sciences, Tokyo University of Science, Noda, Japan.
Oliver ScholleDepartment of Clinical Epidemiology, Leibniz Institute for Prevention Research and Epidemiology-BIPS, Bremen, Germany.
C C M Schuiling-VeningaUnit of PharmacoTherapy, -Epidemiology and -Economics, Groningen Research Institute of Pharmacy, University of Groningen, Groningen, The Netherlands.
Chin-Yao ShenSchool of Pharmacy, Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Tainan, Taiwan.
Ju-Young ShinSchool of Pharmacy, Sungkyunkwan University, Suwon, Gyeonggi-do, South Korea.
Til StürmerDepartment of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
Katja TaxisUnit of PharmacoTherapy, -Epidemiology and -Economics, Groningen Research Institute of Pharmacy, University of Groningen, Groningen, The Netherlands.
Marco TuccoriUnit of Adverse Drug Reactions Monitoring, University Hospital of Pisa, Pisa, Italy.
Stephen WengPrimary Care Stratified Medicine (PRISM) research group, School of Medicine, University of Nottingham, Nottingham, UK.
Kirstie H T W WongDepartment of Paediatrics and Adolescent Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China.
Helga ZoegaCentre of Public Health Sciences, Faculty of Medicine, University of Iceland, Reykjavík, Iceland.
Kenneth K C ManDepartment of Pharmacology and Pharmacy, Li Ka Shing Faculty of Medicine, University of Hong Kong, Hong Kong, China. kenneth.man@ucl.ac.uk.
Ian C K WongDepartment of Pharmacology and Pharmacy, Li Ka Shing Faculty of Medicine, University of Hong Kong, Hong Kong, China. wongick@hku.hk.

Funding

Improving MOUD Access, Opioid-Related Outcomes and Equity Among Medicare Beneficiaries with DisabilityR01DA057568 · NIDA · RUTGERS BIOMEDICAL AND HEALTH SCIENCES · PI Stephen Crystal · 2022 to 2026
$3.7M
Opioid Overdoses among Medicaid Beneficiaries: Predictors, Outcomes, and State Policy EffectsR01DA047347 · NIDA · RUTGERS, THE STATE UNIV OF N.J. · PI CRYSTAL, STEPHEN · 2019 to 2022
$3.1M
NIDA NIH HHS R01 DA047347NIDA NIH HHS R01 DA057568
6 · The paper itself

Abstract

objectiveTo characterize multinational trends and patterns of opioid analgesic prescribing by sex and age. DESIGN, SETTING, AND

participantsWe studied opioid analgesic prescribing from 2001 to 2019 with common protocol using population-based databases from eighteen countries and one special administrative region.

main outcome measuresWe measured opioid prescribing by geographical region, sex and age, estimating annual prevalent, incident, and nonincident opioid prescribing per 100 population with a 95% confidence interval (CI) and meta-analyzed the multinational and regional opioid prescribing with a random-effects model. Time trends were reported through average annual absolute changes, estimated using linear mixed models. We further explored the effect of sex and age on prevalent opioid prescribing in the multivariable analysis.

resultsOver 248 million individuals were included. Pooled multinational opioid prescribing prevalence was 9.0% amongst included countries/regions. Opioid prescribing prevalence in 2015 ranged from 2.7% in Japan to 19.7% in Iceland. Average annual absolute changes in opioid prescribing prevalence per year ranged from - 1.53% (95% CI - 2.06, - 1.00; United States Medicaid) to + 1.24% (95% CI 1.02, 1.46; South Korea). Pooled multinational incident opioid prescribing (4.9%; 95% CI 4.1, 5.9) was higher than pooled multinational nonincident opioid prescribing (3.7%; 95% CI 2.9, 4.8). The female sex and older age were associated with higher opioid prescribing. Main limitations of this study include the absence of data from study duration or individuals not covered by the data sources and the lack of information on medication adherence and indication.

conclusionsOpioid prescribing remains unbalanced across geographical regions; however, results suggest a tendency to convergence across countries/regions. Differences in opioid prescribing by sex and age were identified.

Indexed as

Analgesics, OpioidDrug PrescriptionsPractice Patterns, Physicians'AdolescentAdultAgedAge FactorsDatabases, FactualFemaleHumansInternationalityMaleMiddle AgedSex FactorsYoung AdultAnalgesics, Opioid

Identifiers

PMID40889082
PMCPMC12515243

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.